GB0324919D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0324919D0
GB0324919D0 GB0324919A GB0324919A GB0324919D0 GB 0324919 D0 GB0324919 D0 GB 0324919D0 GB 0324919 A GB0324919 A GB 0324919A GB 0324919 A GB0324919 A GB 0324919A GB 0324919 D0 GB0324919 D0 GB 0324919D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0324919A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Technology Ltd
Original Assignee
Astex Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Technology Ltd filed Critical Astex Technology Ltd
Priority to GB0324919A priority Critical patent/GB0324919D0/en
Publication of GB0324919D0 publication Critical patent/GB0324919D0/en
Priority to TW093120042A priority patent/TWI372050B/en
Priority to PL10195498T priority patent/PL2305250T3/en
Priority to CA2531050A priority patent/CA2531050C/en
Priority to KR1020067000119A priority patent/KR101190964B1/en
Priority to PL04743172T priority patent/PL1648426T3/en
Priority to ES10195498.0T priority patent/ES2457466T3/en
Priority to SI200432125T priority patent/SI1648426T1/en
Priority to MXPA05014223A priority patent/MXPA05014223A/en
Priority to PT47431721T priority patent/PT1648426E/en
Priority to DK04743172.1T priority patent/DK1648426T3/en
Priority to CN2004800249288A priority patent/CN1845734B/en
Priority to DK10195498.0T priority patent/DK2305250T3/en
Priority to PCT/GB2004/002824 priority patent/WO2005002552A2/en
Priority to AU2004253338A priority patent/AU2004253338B2/en
Priority to EP10195498.0A priority patent/EP2305250B1/en
Priority to US10/564,166 priority patent/US7977477B2/en
Priority to JP2006518329A priority patent/JP4833059B2/en
Priority to EP04743172.1A priority patent/EP1648426B1/en
Priority to NZ543959A priority patent/NZ543959A/en
Priority to PT101954980T priority patent/PT2305250E/en
Priority to SI200432146T priority patent/SI2305250T1/en
Priority to ES04743172.1T priority patent/ES2443995T3/en
Priority to IL172840A priority patent/IL172840A/en
Priority to HK06108214.7A priority patent/HK1087925A1/en
Priority to US13/116,121 priority patent/US20110224203A1/en
Priority to US13/902,325 priority patent/US20140010892A1/en
Priority to CY20141100070T priority patent/CY1114846T1/en
Priority to CY20141100311T priority patent/CY1115093T1/en
Ceased legal-status Critical Current

Links

GB0324919A 2003-07-03 2003-10-24 Pharmaceutical compounds Ceased GB0324919D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB0324919A GB0324919D0 (en) 2003-10-24 2003-10-24 Pharmaceutical compounds
TW093120042A TWI372050B (en) 2003-07-03 2004-07-02 (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
ES04743172.1T ES2443995T3 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their uses as protein kinase inhibitors
AU2004253338A AU2004253338B2 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
EP10195498.0A EP2305250B1 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
KR1020067000119A KR101190964B1 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
PL04743172T PL1648426T3 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
ES10195498.0T ES2457466T3 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their uses as protein kinase inhibitors
SI200432125T SI1648426T1 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
MXPA05014223A MXPA05014223A (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors.
PT47431721T PT1648426E (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
DK04743172.1T DK1648426T3 (en) 2003-07-03 2004-07-05 BENZIMIDAZOLD DERIVATIVES AND USE THEREOF AS PROTEINKINASE INHIBITORS
CN2004800249288A CN1845734B (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
DK10195498.0T DK2305250T3 (en) 2003-07-03 2004-07-05 BENZIMIDAZOLD DERIVATIVES AND USE THEREOF AS PROTEINKINASE INHIBITORS
PCT/GB2004/002824 WO2005002552A2 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
PL10195498T PL2305250T3 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
CA2531050A CA2531050C (en) 2003-07-03 2004-07-05 Pharmaceutical compounds
US10/564,166 US7977477B2 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinase inhibitors
JP2006518329A JP4833059B2 (en) 2003-07-03 2004-07-05 Pharmaceutical compounds
EP04743172.1A EP1648426B1 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
NZ543959A NZ543959A (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinase inhibitors
PT101954980T PT2305250E (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
SI200432146T SI2305250T1 (en) 2003-07-03 2004-07-05 Benzimidazole derivatives and their use as protein kinases inhibitors
IL172840A IL172840A (en) 2003-07-03 2005-12-27 Benzimidazole derivatives and their use as protein kinase inhibitors
HK06108214.7A HK1087925A1 (en) 2003-07-03 2006-07-24 Benzimidazole derivatives and their use as protein kinases inhibitors
US13/116,121 US20110224203A1 (en) 2003-07-03 2011-05-26 Benzimidazole derivatives and their use as protein kinase inhibitors
US13/902,325 US20140010892A1 (en) 2003-07-03 2013-05-24 Benzimidazole derivatives and their use as protein kinase inhibitors
CY20141100070T CY1114846T1 (en) 2003-07-03 2014-01-28 BENZIMIDAZOLE PRODUCERS AND THEIR USE OF PROTEIN KINASES
CY20141100311T CY1115093T1 (en) 2003-07-03 2014-04-28 BENZIMIDAZOLE PRODUCERS AND THEIR USE OF PROTEIN KINASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0324919A GB0324919D0 (en) 2003-10-24 2003-10-24 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0324919D0 true GB0324919D0 (en) 2003-11-26

Family

ID=29595815

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0324919A Ceased GB0324919D0 (en) 2003-07-03 2003-10-24 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB0324919D0 (en)

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0218625D0 (en) Pharmaceutical compounds
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0308511D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
EP1778252A4 (en) Noncardiotoxic pharmaceutical compounds
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0317315D0 (en) Pharmaceutical compounds
GB0328490D0 (en) Medicinal compounds
GB0300885D0 (en) Pharmaceutical composition
GB0313766D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
GB2401043B (en) Drug
GB0316889D0 (en) Pharmaceutical agents
GB0306933D0 (en) Pharmaceutical composition
GB0329617D0 (en) Pharmaceutical compounds
GB0307869D0 (en) Pharmaceutical composition
GB0310361D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)